RE-VANA

Our Technology

Re-Vana’s proprietary technologies are based on a novel photo-crosslinked technology.

Our unique photo-crosslinked implants enable us to manufacture products at room temperature and with virtually no change in internal pH. Through photo-crosslinking the implant restricts water movement, thereby maintaining stability of the active drug within the implant matrix and controls the degree of swelling. This results in enhanced protein stability for extended drug delivery. The degree of photo-crosslinking, percentage of drug loaded into the implant, and implant dimension enables Re-Vana to customize the rate and duration of drug delivery.

This novel approach to sustained drug delivery can be used for a wide spectrum of Biologics, Peptides, Large and Small Molecules. Once injected into the eye, the implant slowly biodegrades, releasing the drug at controlled rates for extended periods of time.

Unique crosslink technology

New Re-Vana technology animation demonstrates EyeLief® and OcuLief® delivering sustained release biologics.